Researchers
Čudina, Olivera
Results 1-20 of 102
| Issue Date | Title | Author(s) | Type | Мp-cat. |
|---|---|---|---|---|
| 2026 | Newly Synthesized Telmisartan–Amino Acid Conjugates Exhibit Enhanced Cytotoxic Effects in Malignant Melanoma Cells | Vukadinović, Dragana; Damjanović, Ana   ; Vuković, Miodrag ; Čudina, Olivera ; Grahovac, Jelena ; Dobričić, Vladimir | Article | 21M21 |
| 2025 | Farmaceutska hemija 2 | Čudina, Olivera ; Brborić, Jasmina | Text book | Mp. category will be shown later |
| 2025 | Exploring the redox mechanism of 9-acridinyl amino acid derivatives by electrochemical and theoretical approach | Rupar, Jelena ; Popović-Nikolić, Marija ; Nikolić, Katarina ; Dobričić, Vladimir ; Čudina, Olivera ; Aleksić, Mara | Article | 21M21 |
| 2024 | In Vitro Evaluation of Pharmacokinetic Properties of Selected Dual COX-2 and 5-LOX Inhibitors | Bošković, Jelena ; Dobričić, Vladimir ; Savić, Jelena ; Rupar, Jelena ; Aleksić, Mara ; Marković, Bojan ; Čudina, Olivera | Article | 21aM21a |
| 2024 | Estimation of passive gastrointestinal absorption of new dual DNA gyrase and topoisomerase IV inhibitors using PAMPA and biopartitioning micellar chromatography and quantitative structure-retention relationship analysis | Dobričić, Vladimir ; Marodi, Marko; Marković, Bojan ; Tomašič, Tihomir; Durcik, Martina; Zidar, Nace; Mašič, Peterlin L.; Ilaš, Janez; Kikelj, Danijel; Čudina, Olivera | Article | 22M22 |
| 2024 | High-performance liquid chromatography evaluation of lipophilicity and QSRR modeling of a series of dual DNA gyrase and topoisomerase IV inhibitors | Dobričić, Vladimir ; Savić, Jelena ; Tomašič, Tihomir; Durcik, Martina; Zidar, Nace; Peterlin-Mašič, Lucija; Ilaš, Janez; Kikelj, Danijel; Čudina, Olivera | Article | 22M22 |
| 2024 | Unveiling Anticancer Potential of COX-2 and 5-LOX Inhibitors: Cytotoxicity, Radiosensitization Potential and Antimigratory Activity against Colorectal and Pancreatic Carcinoma | Bošković, Jelena ; Dobričić, Vladimir ; Keta, Otilija ; Korićanac, Lela ; Žakula, Jelena ; Dinić, Jelena ; Jovanović Stojanov, Sofija ; Pavić, Aleksandar; Čudina, Olivera | Article | 21aM21a |
| 2023 | Square wave voltammetric study of interaction between 9-acridinyl amino acid derivatives and DNA | Rupar, Jelena ; Dobričić, Vladimir ; Brborić, Jasmina ; Čudina, Olivera ; Aleksić, Mara | Article | 21aM21a |
| 2023 | Synthesis and investigation of enzyme inhibition of potential dual COX-2 and 5-LOX inhibitors | Bošković, Jelena ; Dobričić, Vladimir ; Nedeljković, Nikola ; Nikolić, Miloš ; Vujić, Zorica ; Čudina, Olivera | Conference Paper | Mp. category will be shown later |
| 2023 | Synthesis, Evaluation of Enzyme Inhibition and Redox Properties of Potential Dual COX-2 and 5-LOX Inhibitors | Bošković, Jelena ; Dobričić, Vladimir ; Mihajlović, Marija ; Kotur-Stevuljević, Jelena ; Čudina, Olivera | Article | 21M21 |
| 2023 | Estimation of lipophilicity of newly synthesized potential COX-2 and 5-LOX inhibitors using RP-HPLC analysis | Bošković, Jelena ; Crevar, Milkica ; Čudina, Olivera ; Dobričić, Vladimir | Conference Paper | Mp. category will be shown later |
| 2023 | Synthesis and cytotoxic activity of selected dual COX-2 and 5-LOX inhibitors in HeLa and MIA PaCa-2 human cancer cell lines | Keta, Otilija D. ; Bošković, Jelena; Petković, Vladana ; Đorđević, Neda O. ; Dobričić, Vladimir ; Čudina, Olivera ; Pajović, Snežana B. | Conference Paper | Mp. category will be shown later |
| 2022 | Synthesis and physicochemical characterization of three newly synthesized sulfhydroxamic acid derivatives as potential dual inhibitors of cyclooxygenase-2 and 5-lipoxygenase enzymes | Bošković, Jelena ; Čudina, Olivera ; Dobričić, Vladimir | Conference Paper | Mp. category will be shown later |
| 2022 | Design of novel dual COX 2 and 5 LOX inhibitors using quantitative structure activity relationships analysis | Bošković, Jelena ; Dobričić, Vladimir ; Ružić, Dušan ; Nikolić, Katarina ; Čudina, Olivera | Conference Paper | Mp. category will be shown later |
| 2022 | Development and validation of high-performance liquid chromatography method for determination of flunixin-meglumine and its impurities in preparations for veterinary use | Zabelaj, Davor; Ivković, Branka ; Čudina, Olivera ; Brborić, Jasmina | Conference Paper | Mp. category will be shown later |
| 2022 | A new simple liquid chromatographic assay for gentamicin in presence of methylparaben and propylparaben | Ivković, Branka ; Milutinović, Ivana; Čudina, Olivera ; Marković, Bojan | Article | 22M22 |
| 2022 | Estimation of lipophilicity and design of new 17β-carboxamide glucocorticoids using RP-HPLC and quantitative structure-retention relationships analysis | Dobričić, Vladimir ; Bošković, Jelena ; Vukadinović, Dragana; Vladimirov, Sote ; Čudina, Olivera | Article | 22M22 |
| 2022 | Design of Dual COX-2 and 5-LOX Inhibitors with Iron-Chelating Properties Using Structure-Based and Ligand-Based Methods | Bošković, Jelena ; Ružić, Dušan ; Čudina, Olivera ; Nikolic, Katarina ; Dobričić, Vladimir | Article | 23M23 |
| 2021 | Current computer-aided drug design methodologies in discovery of novel drug candidates for neuropsychiatric and inflammatory diseases | Radan, Milica ; Bošković, Jelena ; Dobričić, Vladimir ; Čudina, Olivera ; Nikolić, Katarina | Article | 52M52 |
| 2021 | Design of new telmisartan analogues without AT1 receptor antagonistic activity | Dobričić, Vladimir ; Vukadinović, Dragana; Grahovac, Jelena ; Čudina, Olivera | Conference Paper | Mp. category will be shown later |